Cancer Immunotherapy: Funding and Coverage

Over the past decade immunotherapy has transformed treatment for many types of cancer, but it's also one of the most expensive categories in cancer treatment. Some immunotherapy drugs are included in the health basket in certain circumstances, others are not yet, and sometimes the same drug is included for one indication but not another. This article explains how to move forward when you or someone close to you is recommended immunotherapy, and what to check before starting.

What immunotherapy is, and why it's different

Unlike chemotherapy, which directly damages rapidly dividing cells, immunotherapy works by recruiting and strengthening the body's immune system so that it identifies and fights cancer cells. Targeted therapy is a related category that acts on specific mechanisms within the cancer cell. Both categories frequently include expensive biologic drugs, so they require a similar funding check: what's in the basket, what's in your private insurance, and what's available through the exceptions-committee route.

Immunotherapy in the health basket

The health basket today includes several immunotherapy drugs for certain cancer indications, but coverage varies by cancer type, disease stage, and previous treatments already tried. A drug included in the basket for one type of cancer may not be included for another, so it's important to check with the medical team and your HMO whether your specific indication is currently in the basket, rather than relying on what you heard about another patient.

When the drug is outside the basket

When an immunotherapy drug is not included in the basket for the relevant indication, it's usually an out-of-basket drug whose cost can reach tens of thousands of shekels a month. In that situation, the two main options to check are: the private-insurance drug rider, and the exceptions-committee route.

The private-insurance drug rider

Most private health policies include a drug rider that can fund out-of-basket immunotherapy drugs, subject to the list of covered drugs, a copay, and a coverage cap. Since immunotherapy and targeted drugs are part of the group of expensive biologic drugs, it's worth checking the general rules for that category alongside the specific check of the drug recommended to you.

The exceptions-committee route

When a drug isn't on the drug rider's list, in many cases you can still apply to the insurer's exceptions committee and request individual approval, based on a medical opinion and evidence that covered treatments are unsuitable or haven't worked. The process usually requires detailed medical documents, and sometimes takes time — so it's worth starting it as early as possible rather than waiting until the last minute.

Related costs worth remembering

Beyond the cost of the drug itself, immunotherapy treatment usually involves frequent follow-up tests, imaging, and treatment-response assessments, and sometimes side effects that require additional treatment. It's worth checking the general oncology coverage in your policy, not just the drug rider, to understand the full financial picture of the treatment path.

What to actually check

Three practical things: check with the medical team whether the recommended drug is in the basket for your specific indication; check the private-insurance drug rider to see whether it's on the list, and at what cap and copay; and if not, open a request to the exceptions committee as early as possible with all relevant medical documents.

How Ravit can help

Have you been recommended immunotherapy and aren't sure what your insurance covers? Send Ravit the policy on WhatsApp, and she'll help you understand what the drug rider says and what the next steps are.

The information in this article is general only and does not constitute medical, insurance, legal, or pension advice, and is not a substitute for reading your policy terms or consulting a licensed professional. Coverage, amounts, and conditions vary between policies and change over time — always verify against your own specific policy and an authorized professional.